Reporting for the family-office world.

Join the Family Office Networks’ Webinar Series featuring The Lake Nona Performance Club. Under construction and scheduled to open in July 2021, the Lake Nona Performance Club (LNPC) in Orlando will be one of the most thoughtfully curated and all-inclusive health and wellness centers in the nation. It provides a tailored approach to whole-person health for members of all ages and skill levels and empowering participants to overcome injury and disease. The 130,000-square-foot center will redefine the fitness center experience for the region with leading-edge workout equipment, state-of-art classes, and interactive programs driven by the latest performance  technology. LNPC is located in the heart of the 6 million sq. ft. Lake Nona Town Center. This forward-thinking region is transforming the concept of healthy living for the 300,000+ who live and work in this modern mecca for technology and innovation in Orlando.

Join the Family Office Networks’ Webinar Series featuring Equinox Partners.   Gold has proven to be a liquid, uncorrelated asset ideally suited for the current era of uncertainty. With extreme valuations in U.S. equities, very low interest rates, and experimental central bank intervention, the tailwinds for gold are significant. At the same time, precious metals miners are trading at low valuations coupled with a scarcity of active managers willing or able to pick stocks after a prolonged bear market. Equinox Partners, a Connecticut-based investment manager that runs several funds and managed accounts, has over 20 years’ experience in the precious metals mining sector as long-term, contrarian, value investors. The firm’s CIO, Sean Fieler, will lead a discussion on the 10 rules the firm applies to analyzing investments in the sector.  

Join the Family Office Networks community and the management team from OXIO Health, Inc. (OXIO) as they discuss solutions to the current healthcare crisis and the multiple opportunities they have created with industry leadership that brings an outstanding investment opportunity with High Societal Impact. OXIO is the parent company of an initial group of five (5) innovative and relational companies that are poised to enter the market in Q4 2020 to address a number of systemic healthcare problems which are now reaching a breaking point due to the COVID-19 crisis. Healthcare is both the largest industry in the USA and the most complex with healthcare costs forecast to nearly double to more than US$6 trillion in the coming decade. What you will hear in this webinar: How this addressable market of nearly $400 B in healthcare in these segments has limited competition and how OXIO is poised make an impact in a short period of time How a skilled and experienced management team is bringing all these areas under one roof to capitalize on the tremendous economies of scale this creates as well as leveraging its robust IP that could change healthcare permanently How can anyone ignore an opportunity where public companies are selling for 10-30X revenues and companies filing IPOs see share prices double on opening day? You are invited to listen to OXIO’s top industry healthcare experts, visionaries and thought leaders talk about a new type of enterprise that brings technology to the care of patients, including the Medicare population that is growing at a rate of 10,000 persons a day. The team has also developed an innovative capital structure that will allow quick monetization as the company expands. OXIO combines the features of an incubator/accelerator and behaves more like venture capital, thus approaching private equity that it calls a Distributive Venture Platform™. This is a must hear presentation.

Come Join the Family Office Networks’ Webinar Series featuring Asalyxa Bio. Asalyxa Bio’s elegant technology platform enables targeted delivery of therapeutic compounds directly to neutrophils, a key immune cell with relevance to various acute diseases/conditions including COVID-19. This platform is ideal for a variety of diseases where treatments are limited or do not exist.

Background on Company Novel scientific insights to unlock the full potential of B cell therapeutics Range of treatment opportunities for cancer immunotherapy and B cell-driven rare diseases Lead program, AT-1965, advancing toward IND and initiation of solid tumor clinical study in 2H2020 Positive pre-IND interaction with FDA; alignment on 2020 IND submission and clinical initiation for AT-1965 Collaborative team with leadership across all biotech disciplines; premier scientific advisors and leading entrepreneur backers Financing underway to fund AT-1965 clinical initiation and development What you will learn from this webinar How a B cell activation approach differs from other cancer immunotherapy approaches How clinical data drives value creation in cancer immunotherapy How AT-1965 is poised to lead the next frontier in cancer immunotherapy How investment in Akamara will diversify your cancer immunotherapy portfolio Hemptown USA has generated $17.6 million in revenue for 2019 and closed $23M in funding through 2 capital raises. What you will learn from this webinar: About hemp-derived cannabinoids and how Hemptown USA became an established and experienced operator in this emerging industry. The hemp value chain, and Hemptown USA’s diversified revenue approach. What is CBG and why it is the next big cannabinoid. Why Hemptown USA’s production platform and M&A strategy present a unique opportunity for investors.

Join the Family Office Networks Webinar Series Featuring Hemptown USA. Eric Gripentrog, CEO will discuss hemp derived cannabinoids, including CBD and CBG, and the platform that Hemptown USA has built for industry consolidation and integration. Hemptown is a leader in cultivation with a Fortune 500 management team, including leadership from Kellogg and Intel. It is one of the largest producers of CBG globally. Hemptown USA has generated $17.6 million in revenue for 2019 and closed $23M in funding through 2 capital raises. What you will learn from this webinar: About hemp-derived cannabinoids and how Hemptown USA became an established and experienced operator in this emerging industry. The hemp value chain, and Hemptown USA’s diversified revenue approach. What is CBG and why it is the next big cannabinoid. Why Hemptown USA’s production platform and M&A strategy present a unique opportunity for investors.

Come Join the Family Office Networks Webinar Series featuring Impact Venture Capital. Eric Ball, General Partner with Impact will lead a panel discussion that will include Michael Beaudoin of Mark IV Capital and Victoria Cheng of Citi Ventures. Impact Venture Capital is an early-stage firm that partners with top corporate venture arms to invest in applied AI. After a successful Fund I, it is currently raising a $50 million Fund II. What you will learn from this webinar: How are family offices and venture investors adapting to the post-Covid environment for investing in startups? What role can corporate venture arms play in helping early-stage startups mature? How is Impact Venture Capital bringing these players together for better investment returns?

Come join the Family Office Networks Webinar Series Featuring CLICS. CLICS is the first digital hair color studio for stylists and pay per dispense color service for salons. Charles Brown, CEO will discuss the future of color formulation with millions of designable and repeatable colors using the Neural Net Al Solution.

Genprex, Inc is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. What they will learn from this webinar How Genprex is bridging critical gaps in modern medicine by providing new treatment options to patients with cancer and diabetes The Company’s oncology program and its modern combinational treatment approach to fight cancer How its diabetes program could eliminate the need for insulin in diabetic patients At Genprex, they believe their therapies offer a strong value proposition to the market to address unmet medical needs and save lives.

Come join the Family Office Networks Webinar Series featuring Revance. Revance Therapeutics (NASDAQ: RVNC) is a Silicon Valley-based biotechnology company, pioneering new innovations in neuromodulators for aesthetic and therapeutic indications. Tobin Schilke, Chief Financial Officer and Dustin Sjuts, Chief Commercial Officer, Aesthetics & Therapeutics, will speak about the advantages of its next-generation neuromodulator, DaxibotulinumtoxinA for Injection, not only for wrinkle reduction, but also in the treatment of debilitating medical conditions.

In recent years, “sustainable investing”— meaning investment strategies that incorporate environmental, social, and governance (ESG) factors alongside traditional financial analysis — has grown considerably in attention and assets under management (AUM). According to a 2018 study, more than $12 trillion in assets in the U.S. alone were managed in a sustainable process, compared to $639 billion in 19951. We believe this trend will continue and that ESG ETFs will be a significant driver of this growth due to the structural efficiencies’ ETFs provide and the consistently expanding menu of exposure options. The partnership with IndexIQ and CANDRIAM currently offers two ESG ETF Solutions (Tickers: IQSU and IQSI) and are in the process of bringing several “impact” funds to market. 1. Source: “The Forum for Sustainable and Responsible Investment (US SIF),” Trends Report 2018. OXIO is the parent company of an initial group of five (5) innovative and relational companies that are poised to enter the market in Q4 2020 to address a number of systemic healthcare problems which are now reaching a breaking point due to the COVID-19 crisis. Healthcare is both the largest industry in the USA and the most complex with healthcare costs forecast to nearly double to more than US$6 trillion in the coming decade. What you will hear in this webinar: The substantial ROI opportunities, unseen by the typical investor, that exist in direct patient care, technology, IoT and in physical real estate used exclusively in healthcare that OXIO is multiplying through its unique investment vehicle it calls Distributive Venture Platform or DVP How this addressable market of nearly $400 B in healthcare in these segments has limited competition and how OXIO is poised make an impact in a short period of time How a skilled and experienced management team is bringing all these areas under one roof to capitalize on the tremendous economies of scale this creates as well as leveraging its robust IP that could change healthcare permanently How can anyone ignore an opportunity where public companies are selling for 10-30X revenues and companies filing IPOs see share prices double on opening day? You are invited to listen to OXIO’s top industry healthcare experts, visionaries and thought leaders talk about a new type of enterprise that brings technology to the care of patients, including the Medicare population that is growing at a rate of 10,000 persons a day. The team has also developed an innovative capital structure that will allow quick monetization as the company expands. OXIO combines the features of an incubator/accelerator and behaves more like venture capital, thus approaching private equity that it calls a Distributive Venture Platform™. This is a must hear presentation.

Exro Technologies is a software design company that creates an Electric Program Module (EPM), effectively a computer chip that communicates directly with an electric motor and powertrain. Sue Ozdemir, CEO will discuss how Exro technology makes existing electric motors smarter and more efficient. Simplifyy is drastically reducing owner’s operating costs through the implementation of our software and service platform, which eliminates office payroll, administrative, advertising and marketing, and management and accounting costs. We charge one monthly flat rate fee per unit that allows for significantly greater, more predictable cash flow. What you will learn from this webinar: The multifamily property management industry is ripe for innovative disruption. Simplifyy’s SaaS approach to end-to-end property management means a huge upside for apartment owners. Simplifyy’s margins make it an exciting investment opportunity. Simplifyy is currently amidst a $3M-$5M raise to fund software development and operations through break even in 2021. Whether you are interested in identifying new investment, luxury or philanthropic opportunities, partnering with other families and private investors, or just looking around for ideas, we invite you to join us to learn more about FON Marketplace. Registered users are able to filter transactions by key parameters such as liquid net worth, annual income, gender/age, location, preferred investment allocation, philanthropic donations, and luxury purchases. FON Marketplace is open to Family Office Networks’ community including: 15,000+ single and multi-family offices with $50-500M net worth, plus 60,000+ UHNW investors; hedge funds, private equity, venture capital, real estate, blockchain, RIA’s, private and public companies; legal, accounting/tax, cost segregation, fund administration; yachts, private aviation, luxury cars, art, jewelry, butler services/household staff and luxury experiences. To learn more about FON Marketplace’s audience, please click here. We look forward to hearing from you and invite you to register for this complementary demo session.